0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Decitabine Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-32X7761
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Decitabine Market Insights and Forecast to 2028
BUY CHAPTERS

Global Decitabine Market Research Report 2025

Code: QYRE-Auto-32X7761
Report
July 2025
Pages:100
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Decitabine Market

The global market for Decitabine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Decitabine is also known as 5 - nitrogen hetero - 2 "- DNA cytosine nucleoside, 5 - n - 2" - deoxy cytidine acid, is a kind of natural 2 "- deoxy cytidine acid adenosine analogues, by inhibiting the DNA methyltransferase, reduce DNA methylation, thus inhibiting tumor cell proliferation, and prevent the occurrence of drug resistance, for the strongest known DNA methylation specific inhibitor, belongs to the S phase of cell cycle specific drugs, is suitable for the treatment of myelodysplastic syndrome (MDS).
North American market for Decitabine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Decitabine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Decitabine include Johnson & Johnson, Eli Lilly and Company, Pharmachemie B.V., Otsuka Pharmaceutical, Sandoz, Dr Reddy's Laboratories, Accord Healthcare, Sun Pharmaceutical, Cipla, Lupin, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Decitabine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Decitabine.
The Decitabine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Decitabine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Decitabine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Decitabine Market Report

Report Metric Details
Report Name Decitabine Market
Segment by Type
  • 10 Mg Dosage Forms
  • 15 Mg Dosage Forms
  • 25 Mg Dosage Forms
Segment by Application
  • Primary MDS
  • Secondary MDS
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Johnson & Johnson, Eli Lilly and Company, Pharmachemie B.V., Otsuka Pharmaceutical, Sandoz, Dr Reddy's Laboratories, Accord Healthcare, Sun Pharmaceutical, Cipla, Lupin, Shandong Xinshidai Pharmaceutical, Hangzhou Zhongmei Huadong Pharmaceutical, ZHENGDA Tianqing Pharmaceutical Group, Jiangsu Aosaikang Pharmaceutical, Jiangsu Haosen Pharmaceutical Group, Lianyungang Jierui Pharmaceutical, Qilu Pharmaceutical Hainan, Lianyungang Runzhong Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Decitabine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Decitabine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Decitabine Market report?

Ans: The main players in the Decitabine Market are Johnson & Johnson, Eli Lilly and Company, Pharmachemie B.V., Otsuka Pharmaceutical, Sandoz, Dr Reddy's Laboratories, Accord Healthcare, Sun Pharmaceutical, Cipla, Lupin, Shandong Xinshidai Pharmaceutical, Hangzhou Zhongmei Huadong Pharmaceutical, ZHENGDA Tianqing Pharmaceutical Group, Jiangsu Aosaikang Pharmaceutical, Jiangsu Haosen Pharmaceutical Group, Lianyungang Jierui Pharmaceutical, Qilu Pharmaceutical Hainan, Lianyungang Runzhong Pharmaceutical

What are the Application segmentation covered in the Decitabine Market report?

Ans: The Applications covered in the Decitabine Market report are Primary MDS, Secondary MDS

What are the Type segmentation covered in the Decitabine Market report?

Ans: The Types covered in the Decitabine Market report are 10 Mg Dosage Forms, 15 Mg Dosage Forms, 25 Mg Dosage Forms

1 Decitabine Market Overview
1.1 Product Definition
1.2 Decitabine by Type
1.2.1 Global Decitabine Market Value Comparison by Type (2024 VS 2031)
1.2.2 10 Mg Dosage Forms
1.2.3 15 Mg Dosage Forms
1.2.4 25 Mg Dosage Forms
1.3 Decitabine by Application
1.3.1 Global Decitabine Market Value by Application (2024 VS 2031)
1.3.2 Primary MDS
1.3.3 Secondary MDS
1.4 Global Decitabine Market Size Estimates and Forecasts
1.4.1 Global Decitabine Revenue 2020-2031
1.4.2 Global Decitabine Sales 2020-2031
1.4.3 Global Decitabine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Decitabine Market Competition by Manufacturers
2.1 Global Decitabine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Decitabine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Decitabine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Decitabine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Decitabine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Decitabine, Product Type & Application
2.7 Global Key Manufacturers of Decitabine, Date of Enter into This Industry
2.8 Global Decitabine Market Competitive Situation and Trends
2.8.1 Global Decitabine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Decitabine Players Market Share by Revenue
2.8.3 Global Decitabine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Decitabine Market Scenario by Region
3.1 Global Decitabine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Decitabine Sales by Region: 2020-2031
3.2.1 Global Decitabine Sales by Region: 2020-2025
3.2.2 Global Decitabine Sales by Region: 2026-2031
3.3 Global Decitabine Revenue by Region: 2020-2031
3.3.1 Global Decitabine Revenue by Region: 2020-2025
3.3.2 Global Decitabine Revenue by Region: 2026-2031
3.4 North America Decitabine Market Facts & Figures by Country
3.4.1 North America Decitabine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Decitabine Sales by Country (2020-2031)
3.4.3 North America Decitabine Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Decitabine Market Facts & Figures by Country
3.5.1 Europe Decitabine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Decitabine Sales by Country (2020-2031)
3.5.3 Europe Decitabine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Decitabine Market Facts & Figures by Region
3.6.1 Asia Pacific Decitabine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Decitabine Sales by Region (2020-2031)
3.6.3 Asia Pacific Decitabine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Decitabine Market Facts & Figures by Country
3.7.1 Latin America Decitabine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Decitabine Sales by Country (2020-2031)
3.7.3 Latin America Decitabine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Decitabine Market Facts & Figures by Country
3.8.1 Middle East and Africa Decitabine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Decitabine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Decitabine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Decitabine Sales by Type (2020-2031)
4.1.1 Global Decitabine Sales by Type (2020-2025)
4.1.2 Global Decitabine Sales by Type (2026-2031)
4.1.3 Global Decitabine Sales Market Share by Type (2020-2031)
4.2 Global Decitabine Revenue by Type (2020-2031)
4.2.1 Global Decitabine Revenue by Type (2020-2025)
4.2.2 Global Decitabine Revenue by Type (2026-2031)
4.2.3 Global Decitabine Revenue Market Share by Type (2020-2031)
4.3 Global Decitabine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Decitabine Sales by Application (2020-2031)
5.1.1 Global Decitabine Sales by Application (2020-2025)
5.1.2 Global Decitabine Sales by Application (2026-2031)
5.1.3 Global Decitabine Sales Market Share by Application (2020-2031)
5.2 Global Decitabine Revenue by Application (2020-2031)
5.2.1 Global Decitabine Revenue by Application (2020-2025)
5.2.2 Global Decitabine Revenue by Application (2026-2031)
5.2.3 Global Decitabine Revenue Market Share by Application (2020-2031)
5.3 Global Decitabine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Johnson & Johnson
6.1.1 Johnson & Johnson Company Information
6.1.2 Johnson & Johnson Description and Business Overview
6.1.3 Johnson & Johnson Decitabine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Johnson & Johnson Decitabine Product Portfolio
6.1.5 Johnson & Johnson Recent Developments/Updates
6.2 Eli Lilly and Company
6.2.1 Eli Lilly and Company Company Information
6.2.2 Eli Lilly and Company Description and Business Overview
6.2.3 Eli Lilly and Company Decitabine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Eli Lilly and Company Decitabine Product Portfolio
6.2.5 Eli Lilly and Company Recent Developments/Updates
6.3 Pharmachemie B.V.
6.3.1 Pharmachemie B.V. Company Information
6.3.2 Pharmachemie B.V. Description and Business Overview
6.3.3 Pharmachemie B.V. Decitabine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Pharmachemie B.V. Decitabine Product Portfolio
6.3.5 Pharmachemie B.V. Recent Developments/Updates
6.4 Otsuka Pharmaceutical
6.4.1 Otsuka Pharmaceutical Company Information
6.4.2 Otsuka Pharmaceutical Description and Business Overview
6.4.3 Otsuka Pharmaceutical Decitabine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Otsuka Pharmaceutical Decitabine Product Portfolio
6.4.5 Otsuka Pharmaceutical Recent Developments/Updates
6.5 Sandoz
6.5.1 Sandoz Company Information
6.5.2 Sandoz Description and Business Overview
6.5.3 Sandoz Decitabine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Sandoz Decitabine Product Portfolio
6.5.5 Sandoz Recent Developments/Updates
6.6 Dr Reddy's Laboratories
6.6.1 Dr Reddy's Laboratories Company Information
6.6.2 Dr Reddy's Laboratories Description and Business Overview
6.6.3 Dr Reddy's Laboratories Decitabine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Dr Reddy's Laboratories Decitabine Product Portfolio
6.6.5 Dr Reddy's Laboratories Recent Developments/Updates
6.7 Accord Healthcare
6.7.1 Accord Healthcare Company Information
6.7.2 Accord Healthcare Description and Business Overview
6.7.3 Accord Healthcare Decitabine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Accord Healthcare Decitabine Product Portfolio
6.7.5 Accord Healthcare Recent Developments/Updates
6.8 Sun Pharmaceutical
6.8.1 Sun Pharmaceutical Company Information
6.8.2 Sun Pharmaceutical Description and Business Overview
6.8.3 Sun Pharmaceutical Decitabine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Sun Pharmaceutical Decitabine Product Portfolio
6.8.5 Sun Pharmaceutical Recent Developments/Updates
6.9 Cipla
6.9.1 Cipla Company Information
6.9.2 Cipla Description and Business Overview
6.9.3 Cipla Decitabine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Cipla Decitabine Product Portfolio
6.9.5 Cipla Recent Developments/Updates
6.10 Lupin
6.10.1 Lupin Company Information
6.10.2 Lupin Description and Business Overview
6.10.3 Lupin Decitabine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Lupin Decitabine Product Portfolio
6.10.5 Lupin Recent Developments/Updates
6.11 Shandong Xinshidai Pharmaceutical
6.11.1 Shandong Xinshidai Pharmaceutical Company Information
6.11.2 Shandong Xinshidai Pharmaceutical Description and Business Overview
6.11.3 Shandong Xinshidai Pharmaceutical Decitabine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Shandong Xinshidai Pharmaceutical Decitabine Product Portfolio
6.11.5 Shandong Xinshidai Pharmaceutical Recent Developments/Updates
6.12 Hangzhou Zhongmei Huadong Pharmaceutical
6.12.1 Hangzhou Zhongmei Huadong Pharmaceutical Company Information
6.12.2 Hangzhou Zhongmei Huadong Pharmaceutical Description and Business Overview
6.12.3 Hangzhou Zhongmei Huadong Pharmaceutical Decitabine Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Hangzhou Zhongmei Huadong Pharmaceutical Decitabine Product Portfolio
6.12.5 Hangzhou Zhongmei Huadong Pharmaceutical Recent Developments/Updates
6.13 ZHENGDA Tianqing Pharmaceutical Group
6.13.1 ZHENGDA Tianqing Pharmaceutical Group Company Information
6.13.2 ZHENGDA Tianqing Pharmaceutical Group Description and Business Overview
6.13.3 ZHENGDA Tianqing Pharmaceutical Group Decitabine Sales, Revenue and Gross Margin (2020-2025)
6.13.4 ZHENGDA Tianqing Pharmaceutical Group Decitabine Product Portfolio
6.13.5 ZHENGDA Tianqing Pharmaceutical Group Recent Developments/Updates
6.14 Jiangsu Aosaikang Pharmaceutical
6.14.1 Jiangsu Aosaikang Pharmaceutical Company Information
6.14.2 Jiangsu Aosaikang Pharmaceutical Description and Business Overview
6.14.3 Jiangsu Aosaikang Pharmaceutical Decitabine Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Jiangsu Aosaikang Pharmaceutical Decitabine Product Portfolio
6.14.5 Jiangsu Aosaikang Pharmaceutical Recent Developments/Updates
6.15 Jiangsu Haosen Pharmaceutical Group
6.15.1 Jiangsu Haosen Pharmaceutical Group Company Information
6.15.2 Jiangsu Haosen Pharmaceutical Group Description and Business Overview
6.15.3 Jiangsu Haosen Pharmaceutical Group Decitabine Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Jiangsu Haosen Pharmaceutical Group Decitabine Product Portfolio
6.15.5 Jiangsu Haosen Pharmaceutical Group Recent Developments/Updates
6.16 Lianyungang Jierui Pharmaceutical
6.16.1 Lianyungang Jierui Pharmaceutical Company Information
6.16.2 Lianyungang Jierui Pharmaceutical Description and Business Overview
6.16.3 Lianyungang Jierui Pharmaceutical Decitabine Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Lianyungang Jierui Pharmaceutical Decitabine Product Portfolio
6.16.5 Lianyungang Jierui Pharmaceutical Recent Developments/Updates
6.17 Qilu Pharmaceutical Hainan
6.17.1 Qilu Pharmaceutical Hainan Company Information
6.17.2 Qilu Pharmaceutical Hainan Description and Business Overview
6.17.3 Qilu Pharmaceutical Hainan Decitabine Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Qilu Pharmaceutical Hainan Decitabine Product Portfolio
6.17.5 Qilu Pharmaceutical Hainan Recent Developments/Updates
6.18 Lianyungang Runzhong Pharmaceutical
6.18.1 Lianyungang Runzhong Pharmaceutical Company Information
6.18.2 Lianyungang Runzhong Pharmaceutical Description and Business Overview
6.18.3 Lianyungang Runzhong Pharmaceutical Decitabine Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Lianyungang Runzhong Pharmaceutical Decitabine Product Portfolio
6.18.5 Lianyungang Runzhong Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Decitabine Industry Chain Analysis
7.2 Decitabine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Decitabine Production Mode & Process Analysis
7.4 Decitabine Sales and Marketing
7.4.1 Decitabine Sales Channels
7.4.2 Decitabine Distributors
7.5 Decitabine Customer Analysis
8 Decitabine Market Dynamics
8.1 Decitabine Industry Trends
8.2 Decitabine Market Drivers
8.3 Decitabine Market Challenges
8.4 Decitabine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Decitabine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Decitabine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Decitabine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Decitabine Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Decitabine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Decitabine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Decitabine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Decitabine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Decitabine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Decitabine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Decitabine, Product Type & Application
 Table 12. Global Key Manufacturers of Decitabine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Decitabine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Decitabine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Decitabine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Decitabine Sales by Region (2020-2025) & (K Units)
 Table 18. Global Decitabine Sales Market Share by Region (2020-2025)
 Table 19. Global Decitabine Sales by Region (2026-2031) & (K Units)
 Table 20. Global Decitabine Sales Market Share by Region (2026-2031)
 Table 21. Global Decitabine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Decitabine Revenue Market Share by Region (2020-2025)
 Table 23. Global Decitabine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Decitabine Revenue Market Share by Region (2026-2031)
 Table 25. North America Decitabine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Decitabine Sales by Country (2020-2025) & (K Units)
 Table 27. North America Decitabine Sales by Country (2026-2031) & (K Units)
 Table 28. North America Decitabine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Decitabine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Decitabine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Decitabine Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Decitabine Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Decitabine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Decitabine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Decitabine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Decitabine Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Decitabine Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Decitabine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Decitabine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Decitabine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Decitabine Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Decitabine Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Decitabine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Decitabine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Decitabine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Decitabine Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Decitabine Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Decitabine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Decitabine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Decitabine Sales (K Units) by Type (2020-2025)
 Table 51. Global Decitabine Sales (K Units) by Type (2026-2031)
 Table 52. Global Decitabine Sales Market Share by Type (2020-2025)
 Table 53. Global Decitabine Sales Market Share by Type (2026-2031)
 Table 54. Global Decitabine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Decitabine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Decitabine Revenue Market Share by Type (2020-2025)
 Table 57. Global Decitabine Revenue Market Share by Type (2026-2031)
 Table 58. Global Decitabine Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Decitabine Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Decitabine Sales (K Units) by Application (2020-2025)
 Table 61. Global Decitabine Sales (K Units) by Application (2026-2031)
 Table 62. Global Decitabine Sales Market Share by Application (2020-2025)
 Table 63. Global Decitabine Sales Market Share by Application (2026-2031)
 Table 64. Global Decitabine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Decitabine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Decitabine Revenue Market Share by Application (2020-2025)
 Table 67. Global Decitabine Revenue Market Share by Application (2026-2031)
 Table 68. Global Decitabine Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Decitabine Price (US$/Unit) by Application (2026-2031)
 Table 70. Johnson & Johnson Company Information
 Table 71. Johnson & Johnson Description and Business Overview
 Table 72. Johnson & Johnson Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Johnson & Johnson Decitabine Product
 Table 74. Johnson & Johnson Recent Developments/Updates
 Table 75. Eli Lilly and Company Company Information
 Table 76. Eli Lilly and Company Description and Business Overview
 Table 77. Eli Lilly and Company Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Eli Lilly and Company Decitabine Product
 Table 79. Eli Lilly and Company Recent Developments/Updates
 Table 80. Pharmachemie B.V. Company Information
 Table 81. Pharmachemie B.V. Description and Business Overview
 Table 82. Pharmachemie B.V. Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Pharmachemie B.V. Decitabine Product
 Table 84. Pharmachemie B.V. Recent Developments/Updates
 Table 85. Otsuka Pharmaceutical Company Information
 Table 86. Otsuka Pharmaceutical Description and Business Overview
 Table 87. Otsuka Pharmaceutical Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Otsuka Pharmaceutical Decitabine Product
 Table 89. Otsuka Pharmaceutical Recent Developments/Updates
 Table 90. Sandoz Company Information
 Table 91. Sandoz Description and Business Overview
 Table 92. Sandoz Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Sandoz Decitabine Product
 Table 94. Sandoz Recent Developments/Updates
 Table 95. Dr Reddy's Laboratories Company Information
 Table 96. Dr Reddy's Laboratories Description and Business Overview
 Table 97. Dr Reddy's Laboratories Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Dr Reddy's Laboratories Decitabine Product
 Table 99. Dr Reddy's Laboratories Recent Developments/Updates
 Table 100. Accord Healthcare Company Information
 Table 101. Accord Healthcare Description and Business Overview
 Table 102. Accord Healthcare Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Accord Healthcare Decitabine Product
 Table 104. Accord Healthcare Recent Developments/Updates
 Table 105. Sun Pharmaceutical Company Information
 Table 106. Sun Pharmaceutical Description and Business Overview
 Table 107. Sun Pharmaceutical Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Sun Pharmaceutical Decitabine Product
 Table 109. Sun Pharmaceutical Recent Developments/Updates
 Table 110. Cipla Company Information
 Table 111. Cipla Description and Business Overview
 Table 112. Cipla Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Cipla Decitabine Product
 Table 114. Cipla Recent Developments/Updates
 Table 115. Lupin Company Information
 Table 116. Lupin Description and Business Overview
 Table 117. Lupin Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Lupin Decitabine Product
 Table 119. Lupin Recent Developments/Updates
 Table 120. Shandong Xinshidai Pharmaceutical Company Information
 Table 121. Shandong Xinshidai Pharmaceutical Description and Business Overview
 Table 122. Shandong Xinshidai Pharmaceutical Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Shandong Xinshidai Pharmaceutical Decitabine Product
 Table 124. Shandong Xinshidai Pharmaceutical Recent Developments/Updates
 Table 125. Hangzhou Zhongmei Huadong Pharmaceutical Company Information
 Table 126. Hangzhou Zhongmei Huadong Pharmaceutical Description and Business Overview
 Table 127. Hangzhou Zhongmei Huadong Pharmaceutical Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Hangzhou Zhongmei Huadong Pharmaceutical Decitabine Product
 Table 129. Hangzhou Zhongmei Huadong Pharmaceutical Recent Developments/Updates
 Table 130. ZHENGDA Tianqing Pharmaceutical Group Company Information
 Table 131. ZHENGDA Tianqing Pharmaceutical Group Description and Business Overview
 Table 132. ZHENGDA Tianqing Pharmaceutical Group Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. ZHENGDA Tianqing Pharmaceutical Group Decitabine Product
 Table 134. ZHENGDA Tianqing Pharmaceutical Group Recent Developments/Updates
 Table 135. Jiangsu Aosaikang Pharmaceutical Company Information
 Table 136. Jiangsu Aosaikang Pharmaceutical Description and Business Overview
 Table 137. Jiangsu Aosaikang Pharmaceutical Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Jiangsu Aosaikang Pharmaceutical Decitabine Product
 Table 139. Jiangsu Aosaikang Pharmaceutical Recent Developments/Updates
 Table 140. Jiangsu Haosen Pharmaceutical Group Company Information
 Table 141. Jiangsu Haosen Pharmaceutical Group Description and Business Overview
 Table 142. Jiangsu Haosen Pharmaceutical Group Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Jiangsu Haosen Pharmaceutical Group Decitabine Product
 Table 144. Jiangsu Haosen Pharmaceutical Group Recent Developments/Updates
 Table 145. Lianyungang Jierui Pharmaceutical Company Information
 Table 146. Lianyungang Jierui Pharmaceutical Description and Business Overview
 Table 147. Lianyungang Jierui Pharmaceutical Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Lianyungang Jierui Pharmaceutical Decitabine Product
 Table 149. Lianyungang Jierui Pharmaceutical Recent Developments/Updates
 Table 150. Qilu Pharmaceutical Hainan Company Information
 Table 151. Qilu Pharmaceutical Hainan Description and Business Overview
 Table 152. Qilu Pharmaceutical Hainan Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Qilu Pharmaceutical Hainan Decitabine Product
 Table 154. Qilu Pharmaceutical Hainan Recent Developments/Updates
 Table 155. Lianyungang Runzhong Pharmaceutical Company Information
 Table 156. Lianyungang Runzhong Pharmaceutical Description and Business Overview
 Table 157. Lianyungang Runzhong Pharmaceutical Decitabine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 158. Lianyungang Runzhong Pharmaceutical Decitabine Product
 Table 159. Lianyungang Runzhong Pharmaceutical Recent Developments/Updates
 Table 160. Key Raw Materials Lists
 Table 161. Raw Materials Key Suppliers Lists
 Table 162. Decitabine Distributors List
 Table 163. Decitabine Customers List
 Table 164. Decitabine Market Trends
 Table 165. Decitabine Market Drivers
 Table 166. Decitabine Market Challenges
 Table 167. Decitabine Market Restraints
 Table 168. Research Programs/Design for This Report
 Table 169. Key Data Information from Secondary Sources
 Table 170. Key Data Information from Primary Sources
 Table 171. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Decitabine
 Figure 2. Global Decitabine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Decitabine Market Share by Type: 2024 & 2031
 Figure 4. 10 Mg Dosage Forms Product Picture
 Figure 5. 15 Mg Dosage Forms Product Picture
 Figure 6. 25 Mg Dosage Forms Product Picture
 Figure 7. Global Decitabine Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Decitabine Market Share by Application: 2024 & 2031
 Figure 9. Primary MDS
 Figure 10. Secondary MDS
 Figure 11. Global Decitabine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Decitabine Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Decitabine Sales (2020-2031) & (K Units)
 Figure 14. Global Decitabine Average Price (US$/Unit) & (2020-2031)
 Figure 15. Decitabine Report Years Considered
 Figure 16. Decitabine Sales Share by Manufacturers in 2024
 Figure 17. Global Decitabine Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Decitabine Players: Market Share by Revenue in Decitabine in 2024
 Figure 19. Decitabine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Decitabine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Decitabine Sales Market Share by Country (2020-2031)
 Figure 22. North America Decitabine Revenue Market Share by Country (2020-2031)
 Figure 23. U.S. Decitabine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Decitabine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Decitabine Sales Market Share by Country (2020-2031)
 Figure 26. Europe Decitabine Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Decitabine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Decitabine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Decitabine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Decitabine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Decitabine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Decitabine Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Decitabine Revenue Market Share by Region (2020-2031)
 Figure 34. China Decitabine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Decitabine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Decitabine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Decitabine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Decitabine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Taiwan Decitabine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Decitabine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Decitabine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Decitabine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Philippines Decitabine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Decitabine Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Decitabine Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Decitabine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Decitabine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Decitabine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Decitabine Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Decitabine Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Decitabine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Decitabine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Decitabine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Decitabine by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Decitabine by Type (2020-2031)
 Figure 56. Global Decitabine Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Decitabine by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Decitabine by Application (2020-2031)
 Figure 59. Global Decitabine Price (US$/Unit) by Application (2020-2031)
 Figure 60. Decitabine Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String